Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00269568 · ClinicalTrials.gov registry record · Phase 4
Mifepristone at Same Time Multicenter Study
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,128
- Enrollment target
NCT00269568: Completed Phase 4 study, sponsored by University of Pittsburgh.
NCT00269568 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,128 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (118% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00269568, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,128 participants
- Enrollment target
Study Summary
This is a multicenter, randomized study. 564 healthy women, age 18 years or older, with an intrauterine pregnancy, and requesting a medical abortion, will be recruited to participate in this prospective clinical trial. This study will provide an evaluation of oral mifepristone 200 mg and vaginal misoprostol 800 mcg administered simultaneously in women up to 63 days gestation. The aims of the study are to compare the complete abortion rates, at 7 and 14 days after misoprostol administration, when using mifepristone 200 mg orally and misoprostol 800 mcg vaginally are administered simultaneously and 24 hours apart in women up to 63 days gestation. Assessment of side effects (nausea, vomiting, pain) as well as acceptability will be done using pre and post-study questionnaires, and visual analogue scales. Complete abortion rate within 24 hours is expected to be 90%
Interventions
- DRUG mifepristone and misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,128 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 4 |
What the finished NCT00269568 record still lists
NCT00269568 is an interventional study that assigns participants to a tested intervention. Its 1,128 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (118% higher).
The record links to 0 conditions, and to 1 intervention - of which mifepristone and misoprostol is the first listed.
NCT00269568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00269568 about?
NCT00269568 is a clinical study titled "Mifepristone at Same Time Multicenter Study". This is a multicenter, randomized study. 564 healthy women, age 18 years or older, with an intrauterine pregnancy, and requesting a medical abortion, will be recruited to participate in this prospective clinical trial. This study will provide an evaluation of oral mifepristone 200 mg and vaginal mis...
What is the current status of trial NCT00269568?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,128 participants. The study started on 2004-06. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00269568?
The interventions under investigation include: mifepristone and misoprostol (DRUG).
Who is sponsoring clinical trial NCT00269568?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00269568's enrollment target sits among peer trials
1,128 64th of 2000 higher than 1,937 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
- NCT04421768 · 1,125 participants · NA
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
- NCT06895148 · 1,125 participants · NA
ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia